Reply to Farrugia: Appropriately specifying the quality of plasma for fractionation. | Vox Sang;117(3): 460-461, 2022 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Reply to Farrugia: Appropriately specifying the quality of plasma for fractionation.

Siekmann, Jürgen; Weber, Alfred; Bauer, Christoph; Turecek, Peter L.

Siekmann J; Baxalta Innovations GmbH, part of Takeda, Vienna, Austria.
Weber A; Baxalta Innovations GmbH, part of Takeda, Vienna, Austria.
Bauer C; Baxter AG, part of Takeda, Vienna, Austria.
Turecek PL; Baxalta Innovations GmbH, part of Takeda, Vienna, Austria.

Vox Sang ; 117(3): 460-461, 2022 03.

Article in English | MEDLINE | ID: covidwho-1752757

Subject(s)

Plasma; Humans; Quality Control

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasma Limits: Humans Language: English Journal: Vox Sang Year: 2022 Document Type: Article Affiliation country: Vox.13185

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasma Limits: Humans Language: English Journal: Vox Sang Year: 2022 Document Type: Article Affiliation country: Vox.13185